Cesarean Hysterectomy in a Hybrid Operating Room for Placenta Percreta: a Report of Three Cases

Overview

Journal JA Clin Rep

Date 2020 Feb 7

PMID 32026036

Citations 1

Authors

Takashige Yamada

Eriko Hirahata

Naho Ihara

Daisuke Nishimura

Kei Inoue

Jungo Kato

Hiromasa Nagata

Shizuka Minamishima

Hiroshi Morisaki

Affiliations

Soon will be listed here.

Abstract

Background: Placenta percreta is the most severe abnormality in invasive placenta and often treated with cesarean hysterectomy. Endovascular embolization for placental abnormality is known to reduce bleeding from the placental bed and from the abnormal neovasculature surrounding the uterus. We describe three cases of placenta percreta treated with uninterrupted cesarean hysterectomy and embolization performed using a hybrid operating room (HOR).

Case Description: Cases were two placenta previa percretas and an impending uterine rupture with placenta percreta, treated with elective cesarean hysterectomy in HOR. Planned conversion of spinal to general anesthesia was performed after the fetal delivery. Immediate embolic devascularization of abnormal neovasculature was directly observed and facilitated adhesiolysis. Surgical blood losses were 1850 g, 2500 g, and 1180 g, respectively.

Conclusion: Cesarean hysterectomy combined with endovascular embolization in the HOR for placenta percreta is an advantageous option to enhance patient safety by multidisciplinary approach without patient transfer.

Citing Articles

The intraoperative use of internal iliac artery balloon catheters in cesarean deliveries for abnormal invasive placentation: A 3-year retrospective cohort review in Doha, Qatar.

Ahmed H, Minisha F, Babarinsa I, Omar A, Bayo A, Omar K Qatar Med J. 2021; 2021(1):8.

PMID: 33828954 PMC: 7961153. DOI: 10.5339/qmj.2021.8.

References

Konishi Y, Yamamoto S, Sugiki K, Sakamoto H, Sawamura S . A Novel and Multidisciplinary Strategy for Cesarean Delivery With Placenta Percreta: Intraoperative Embolization in a Hybrid Suite. A A Case Rep. 2016; 7(6):135-8. DOI: 10.1213/XAA.0000000000000375. View

Jia L, Wang H, Gao Y, Liu H, Yu K . High incidence of adverse events during intra-hospital transport of critically ill patients and new related risk factors: a prospective, multicenter study in China. Crit Care. 2016; 20:12. PMC: 4717618. DOI: 10.1186/s13054-016-1183-y. View

Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort M . FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet. 2018; 140(3):281-290. DOI: 10.1002/ijgo.12409. View

Bouvier A, Sentilhes L, Thouveny F, Bouet P, Gillard P, Willoteaux S . Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. Clin Radiol. 2012; 67(11):1089-94. DOI: 10.1016/j.crad.2012.04.001. View

Matsuzaki S, Yoshino K, Endo M, Kakigano A, Takiuchi T, Kimura T . Conservative management of placenta percreta. Int J Gynaecol Obstet. 2017; 140(3):299-306. DOI: 10.1002/ijgo.12411. View

Shahin Y, Pang C . Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis. Eur Radiol. 2018; 28(7):2713-2726. DOI: 10.1007/s00330-017-5222-0. View

OBrien J, Barton J, Donaldson E . The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996; 175(6):1632-8. DOI: 10.1016/s0002-9378(96)70117-5. View

Fox K, Shamshirsaz A, Carusi D, Secord A, Lee P, Turan O . Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015; 213(6):755-60. DOI: 10.1016/j.ajog.2015.04.034. View

Clark A, Farber M, Sviggum H, Camann W . Cesarean delivery in the hybrid operating suite: a promising new location for high-risk obstetric procedures. Anesth Analg. 2013; 117(5):1187-9. DOI: 10.1213/ANE.0b013e3182a00aff. View

10.

Sumigama S, Itakura A, Ota T, Okada M, Kotani T, Hayakawa H . Placenta previa increta/percreta in Japan: a retrospective study of ultrasound findings, management and clinical course. J Obstet Gynaecol Res. 2007; 33(5):606-11. DOI: 10.1111/j.1447-0756.2007.00619.x. View

11.

Clausen C, Lonn L, Langhoff-Roos J . Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2013; 93(2):138-43. DOI: 10.1111/aogs.12295. View

12.

Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W . Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2009; 202(1):38.e1-9. DOI: 10.1016/j.ajog.2009.08.037. View

13.

Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E . FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018; 140(3):291-298. DOI: 10.1002/ijgo.12410. View